United States · FDA National Drug Code directory
Psorinum Miasm Drops 2054
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63083-2054_726b36aa-ea68-41c3-bea2-f13cd4c8c4d3
- Product NDC
- 63083-2054
- Form
- LIQUID
- Composition / generic term
- Psorinum Miasm Drops
- Labeler
- Professional Complementary Health Formulas
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 19840815
- Source listing expiry
- 20271231
Source-listed ingredients
- ARSENIC TRIOXIDE — 30 [hp_X]/59mL
- BARIUM CARBONATE — 30 [hp_X]/59mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE — 30 [hp_X]/59mL
- GRAPHITE — 30 [hp_X]/59mL
- CALCIUM SULFIDE — 30 [hp_X]/59mL
- IODINE — 30 [hp_X]/59mL
- MERCURIUS SOLUBILIS — 30 [hp_X]/59mL
- SODIUM CHLORIDE — 30 [hp_X]/59mL
- PHOSPHORUS — 30 [hp_X]/59mL
- SILICON DIOXIDE — 30 [hp_X]/59mL
- SULFUR — 30 [hp_X]/59mL
- SCABIES LESION LYSATE (HUMAN) — 30 [hp_X]/59mL
These values do not establish equivalence or a dose recommendation.
Packages
- 59 mL in 1 BOTTLE, DROPPER (63083-2054-2) · 63083-2054-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →